相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
Hongde Hu et al.
EUROPEAN HEART JOURNAL (2021)
Parvovirus B19-induced angiogenesis in fulminant myocarditis
Maximilian Ackermann et al.
EUROPEAN HEART JOURNAL (2020)
Clinically suspected myocarditis in the course of coronavirus infection
Krzysztof Ozieranski et al.
EUROPEAN HEART JOURNAL (2020)
Fulminant myocarditis in the time of coronavirus
Vittoria Cuomo et al.
EUROPEAN HEART JOURNAL (2020)
Deleterious effects of viral pneumonia on cardiovascular system
Jiahao Duan et al.
EUROPEAN HEART JOURNAL (2020)
Immune-mediated mechanism in coronavirus fulminant myocarditis
Xin Wei et al.
EUROPEAN HEART JOURNAL (2020)
Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19
Michele M. Ciulla
EUROPEAN HEART JOURNAL (2020)
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
Iziah E. Sama et al.
EUROPEAN HEART JOURNAL (2020)
At the heart of COVID-19
Pierpaolo Pellicori
EUROPEAN HEART JOURNAL (2020)
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy
Riccardo M. Inciardi et al.
EUROPEAN HEART JOURNAL (2020)
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
Alaide Chieffo et al.
EUROPEAN HEART JOURNAL (2020)
Is fulminant myocarditis caused by circulating human coronaviruses?
Ryan K. Dare
EUROPEAN HEART JOURNAL (2020)
COVID-19-related myocarditis in a 21-year-old female patient
In-Cheol Kim et al.
EUROPEAN HEART JOURNAL (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Coronaviruses and the cardiovascular system: acute and long-term implications
Tian-Yuan Xiong et al.
EUROPEAN HEART JOURNAL (2020)
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
Alaide Chieffo et al.
EUROPEAN HEART JOURNAL (2020)
Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19
Michele M. Ciulla
EUROPEAN HEART JOURNAL (2020)
Is fulminant myocarditis caused by circulating human coronaviruses?
Ryan K. Dare
EUROPEAN HEART JOURNAL (2020)
Deleterious effects of viral pneumonia on cardiovascular system
Jiahao Duan et al.
EUROPEAN HEART JOURNAL (2020)
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy
Riccardo M. Inciardi et al.
EUROPEAN HEART JOURNAL (2020)
COVID-19-related myocarditis in a 21-year-old female patient
In-Cheol Kim et al.
EUROPEAN HEART JOURNAL (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
At the heart of COVID-19
Pierpaolo Pellicori
EUROPEAN HEART JOURNAL (2020)
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors
Iziah E. Sama et al.
EUROPEAN HEART JOURNAL (2020)
Immune-mediated mechanism in coronavirus fulminant myocarditis
Xin Wei et al.
EUROPEAN HEART JOURNAL (2020)
Coronaviruses and the cardiovascular system: acute and long-term implications
Tian-Yuan Xiong et al.
EUROPEAN HEART JOURNAL (2020)
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
Michael Boehm et al.
EUROPEAN HEART JOURNAL (2018)
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014
Karolina Szummer et al.
EUROPEAN HEART JOURNAL (2018)
Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score matched cohort study
Gianluigi Savarese et al.
EUROPEAN HEART JOURNAL (2018)
Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study
Andrzej Ciszewski et al.
EUROPEAN HEART JOURNAL (2008)
Myocardial infarction increases ACE2 expression in rat and humans
LM Burrell et al.
EUROPEAN HEART JOURNAL (2005)
分享论文
